REVIEW
|
doi:10.20944/preprints202308.0055.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
COVID-19; SARS-CoV-2 Mpro; protease inhibitors; coronavirus; peptidomimetics; Paxlovid; Nirmatrelvir
Online: 2 August 2023 (05:25:21 CEST)